Patient‐focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2022-03, Vol.97 (3), p.E93-E95
Hauptverfasser:	Bradford, Christopher, Miodownik, Hope, Thomas, Merin, Ogu, Ugochi O., Minniti, Caterina P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anemia, Sickle Cell - drug therapy Female Hematology Humans Hydroxyurea Hydroxyurea - administration & dosage Male Medication Adherence Sickle cell disease
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	E95
container_issue	3
container_start_page	E93
container_title	American journal of hematology
container_volume	97
creator	Bradford, Christopher Miodownik, Hope Thomas, Merin Ogu, Ugochi O. Minniti, Caterina P.
description
doi_str_mv	10.1002/ajh.26438
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2610911107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2610911107</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3888-157209073333d10d1524dd5206bdc48a20650e1da0f29d7c33a2855a84df778f3</originalsourceid><addsrcrecordid>eNp1kc1KJDEUhYMo2tO68AWGgBtn0XqT1E9qKaKjIjiLcV3EJEWnpzppkwpaC8FH8BnnSeY6rS4Es8mBfPfcQw4h-wyOGAA_Vov5Ea8KITfIhEFTzWRV8k0yAVEx1NDskG8pLQAYKyRskx1RNKxgAibk6ZcanPXD3-eXLuicrKHO32cXRxo8nY8mhscxR6voMLdRrUaqDArrtaXKG4ovKfhEuxCpcUkHPzif0ROnnUc490OiD26Y0-T0n95Sbfv-FcVBu0u2OtUnu_d2T8nt-dnv04vZ9c3Py9OT65kWUsoZK2sODdQCj2FgWMkLY0oO1Z3RhVQoSrDMKOh4Y2othOKyLJUsTFfXshNTcrj2XcVwn20a2iVmxSDK25BTyyv8NsYYrpiSg0_oIuToMR1SvAJRVAKQ-rGmdAwpRdu1q-iWKo4tg_a1kxY7af93guz3N8d8t7Tmg3wvAYHjNfDgejt-7dSeXF2sLf8BQZmXRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2626034630</pqid></control><display><type>article</type><title>Patient‐focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Bradford, Christopher ; Miodownik, Hope ; Thomas, Merin ; Ogu, Ugochi O. ; Minniti, Caterina P.</creator><creatorcontrib>Bradford, Christopher ; Miodownik, Hope ; Thomas, Merin ; Ogu, Ugochi O. ; Minniti, Caterina P.</creatorcontrib><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.26438</identifier><identifier>PMID: 34914130</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Adult ; Anemia, Sickle Cell - drug therapy ; Female ; Hematology ; Humans ; Hydroxyurea ; Hydroxyurea - administration & dosage ; Male ; Medication Adherence ; Sickle cell disease</subject><ispartof>American journal of hematology, 2022-03, Vol.97 (3), p.E93-E95</ispartof><rights>2021 Wiley Periodicals LLC.</rights><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3888-157209073333d10d1524dd5206bdc48a20650e1da0f29d7c33a2855a84df778f3</citedby><cites>FETCH-LOGICAL-c3888-157209073333d10d1524dd5206bdc48a20650e1da0f29d7c33a2855a84df778f3</cites><orcidid>0000-0002-7059-2959 ; 0000-0002-4662-1414</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.26438$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.26438$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34914130$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bradford, Christopher</creatorcontrib><creatorcontrib>Miodownik, Hope</creatorcontrib><creatorcontrib>Thomas, Merin</creatorcontrib><creatorcontrib>Ogu, Ugochi O.</creatorcontrib><creatorcontrib>Minniti, Caterina P.</creatorcontrib><title>Patient‐focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><subject>Adult</subject><subject>Anemia, Sickle Cell - drug therapy</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Hydroxyurea</subject><subject>Hydroxyurea - administration & dosage</subject><subject>Male</subject><subject>Medication Adherence</subject><subject>Sickle cell disease</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1KJDEUhYMo2tO68AWGgBtn0XqT1E9qKaKjIjiLcV3EJEWnpzppkwpaC8FH8BnnSeY6rS4Es8mBfPfcQw4h-wyOGAA_Vov5Ea8KITfIhEFTzWRV8k0yAVEx1NDskG8pLQAYKyRskx1RNKxgAibk6ZcanPXD3-eXLuicrKHO32cXRxo8nY8mhscxR6voMLdRrUaqDArrtaXKG4ovKfhEuxCpcUkHPzif0ROnnUc490OiD26Y0-T0n95Sbfv-FcVBu0u2OtUnu_d2T8nt-dnv04vZ9c3Py9OT65kWUsoZK2sODdQCj2FgWMkLY0oO1Z3RhVQoSrDMKOh4Y2othOKyLJUsTFfXshNTcrj2XcVwn20a2iVmxSDK25BTyyv8NsYYrpiSg0_oIuToMR1SvAJRVAKQ-rGmdAwpRdu1q-iWKo4tg_a1kxY7af93guz3N8d8t7Tmg3wvAYHjNfDgejt-7dSeXF2sLf8BQZmXRA</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Bradford, Christopher</creator><creator>Miodownik, Hope</creator><creator>Thomas, Merin</creator><creator>Ogu, Ugochi O.</creator><creator>Minniti, Caterina P.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7059-2959</orcidid><orcidid>https://orcid.org/0000-0002-4662-1414</orcidid></search><sort><creationdate>20220301</creationdate><title>Patient‐focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease</title><author>Bradford, Christopher ; Miodownik, Hope ; Thomas, Merin ; Ogu, Ugochi O. ; Minniti, Caterina P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3888-157209073333d10d1524dd5206bdc48a20650e1da0f29d7c33a2855a84df778f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Anemia, Sickle Cell - drug therapy</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Hydroxyurea</topic><topic>Hydroxyurea - administration & dosage</topic><topic>Male</topic><topic>Medication Adherence</topic><topic>Sickle cell disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bradford, Christopher</creatorcontrib><creatorcontrib>Miodownik, Hope</creatorcontrib><creatorcontrib>Thomas, Merin</creatorcontrib><creatorcontrib>Ogu, Ugochi O.</creatorcontrib><creatorcontrib>Minniti, Caterina P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bradford, Christopher</au><au>Miodownik, Hope</au><au>Thomas, Merin</au><au>Ogu, Ugochi O.</au><au>Minniti, Caterina P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient‐focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>97</volume><issue>3</issue><spage>E93</spage><epage>E95</epage><pages>E93-E95</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>34914130</pmid><doi>10.1002/ajh.26438</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-7059-2959</orcidid><orcidid>https://orcid.org/0000-0002-4662-1414</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0361-8609
ispartof	American journal of hematology, 2022-03, Vol.97 (3), p.E93-E95
issn	0361-8609 1096-8652
language	eng
recordid	cdi_proquest_miscellaneous_2610911107
source	MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Free Content; EZB-FREE-00999 freely available EZB journals
subjects	Adult Anemia, Sickle Cell - drug therapy Female Hematology Humans Hydroxyurea Hydroxyurea - administration & dosage Male Medication Adherence Sickle cell disease
title	Patient‐focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A08%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient%E2%80%90focused%20inquiry%20on%20hydroxyurea%20therapy%20adherence%20and%20reasons%20for%20discontinuation%20in%20adults%20with%20sickle%20cell%20disease&rft.jtitle=American%20journal%20of%20hematology&rft.au=Bradford,%20Christopher&rft.date=2022-03-01&rft.volume=97&rft.issue=3&rft.spage=E93&rft.epage=E95&rft.pages=E93-E95&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.26438&rft_dat=%3Cproquest_cross%3E2610911107%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2626034630&rft_id=info:pmid/34914130&rfr_iscdi=true